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Abstract: We characterise the performance of a beam enhancing element 
(‘photon diode’) for use in deep Raman spectroscopy (DRS) of biological 
tissues. The optical component enhances the number of laser photons 
coupled into a tissue sample by returning escaping photons back into it at 
the illumination zone. The method is compatible with transmission Raman 
spectroscopy, a deep Raman spectroscopy concept, and its implementation 
leads to considerable enhancement of detected Raman photon rates. In the 
past, the enhancement concept was demonstrated with a variety of samples 
(pharmaceutical tablets, tissue, etc) but it was not systematically 
characterized with biological tissues. In this study, we investigate the 
enhancing properties of the photon diode in the transmission Raman 
geometry as a function of: a) the depth and b) the optical properties of tissue 
samples. Liquid tissue phantoms were employed to facilitate systematic 
variation of optical properties. These were chosen to mimic optical 
properties of human tissues, including breast and prostate. The obtained 
results evidence that a photon diode can enhance Raman signals of tissues 
by a maximum of × 2.4, although it can also decrease the signals created 
towards the back of samples that exhibit high scattering or absorption 
properties. 
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1. Introduction 
Deep Raman spectroscopy (DRS), comprising principally of Spatially Offset Raman 
Spectroscopy (SORS) [1] and Transmission Raman Spectroscopy (TRS) [2], has been 
established in recent years as a promising tool for non-invasive disease diagnostics. The 
encompassing techniques can achieve a depth range of up to two orders of magnitude higher 
than conventional Raman spectroscopy [3], paving the way for novel medical diagnosis and 
other medical analytical applications in vivo. 
Deep Raman techniques in turbid media are characterized by weak Raman signals due to 
diffuse scattering (and potentially absorption) of photons propagating through these samples. 
This poses a particular challenge when it comes to recovering Raman signals from deeper 
layers in biological tissue. To improve Raman signal to noise ratios, traditional methods, such 
as the increase of laser power, collection time, improvement of collection efficiency etc., can 
be used [4]. Further improvements can be made by employing a signal enhancing element, a 
“photon diode”, which was shown to provide a multifold enhancement of Raman signal in 
powder samples. This can be beneficial as an additional route to boosting accessible depths 
and sensitivity of deep Raman spectroscopy. 
A photon diode comprises a dielectric bandpass filter which increases the collected Raman 
signal from a highly scattering sample when placed in close proximity to the sample surface 
centred on the laser illuminating zone. It acts, in essence, as a unidirectional mirror allowing 
photons of a given wavelength and angle of incidence (e.g. at normal incidence) to be 
transmitted through it on one side whilst the photons re-emitted from the diffusely scattering 
sample (a dominant loss mechanism in TRS of tissue and other diffusely scattering samples) 
to be reflected from it back into the sample due to the angular dependence of its reflectance 
properties [5]. In this way, the element prevents the loss of diffusely scattered photons which 
re-emerge from the sample at the point where the laser beam enters the sample, while it 
allows the collimated laser beam impacting on it at normal incidence to be transmitted 
through the filter from the other side. 
The photon diode has been used in various deep Raman studies in the past, predominantly 
to achieve signal enhancement, mainly with pharmaceutical tablets. The photon diode 
enhancement of pharmaceutical tablets in a transmission mode is typically in the range of × 4- 
× 10 of the mean volume signal when the tablet thickness varies between 3 and 7 mm [5–8]. 
The mechanism of enhancement has also been studied using Monte Carlo simulations 
yielding corresponding enhancement factors [5, 8]. A modified version of the photon diode 
element is also applicable in the SORS modality where it has been demonstrated for a 4.2 mm 
two-layer pharmaceutical tablet, exhibiting enhancement by a factor of × 4.5 for the front 
layer and × 2.2 for the back layer [9]. Further investigation of the enhanced Raman signal as a 
function of layer depth has been conducted while probing a thin film of polymer into different 
depths of a 4 mm tablet, showing an overall enhancement of × 6 experimentally and × 4 using 
numerical models [10]. Alternative enhancement methods include hemispherical mirrors also 
returning emerging photons back into the sample at the illumination zone with reported 
enhancement factors of up to × 40 in 6.35 mm thick pharmaceutical tablets [11]. 
Studies exploring the dependence of Raman signal on the depth of its origin in biological 
samples have also been performed [12], but without the use of photon diode. Separate Raman 
measurements on biological tissue using a photon diode, reported an enhancement factor of × 
1.6 for the mean volume signal of a 14 mm thick chicken breast [8] and × 1.5 for a high-
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Raman scatterer buried in a 2.7 mm depth of 27 mm porcine tissue [4], while both of the 
tissue samples were used to simulate a human breast. 
The photon diode enhancement of Raman signals as a function of the depth of their origin 
is an aspect that has not been explored yet in biological tissue samples. Large differences 
between the optical properties of biological tissues and pharmaceutical tablets, such as the 
lack of absorption in tablets and the mean free scattering path length in tissues due to the 
difference in spatial scales does not allow us to assume identical behavior. In this paper, we 
explore the dependence of photon diode signal enhancement not only on the signal source 
depth but also on tissue optical properties using liquid tissue phantoms. The 30 mm thickness 
phantoms employed were of similar optical properties to various human tissues, and of similar 
dimensions to particularly breast and prostate. The tissue phantoms consisted of a scattering 
agent, an absorption agent and a high Raman cross-section compound located at a given depth 
representing, for example, a malignant element found in many cancerous conditions (e.g. 
calcifications). The purpose of this study was to characterise the enhancement effect of the 
photon diode as a function of the inclusion depth inside the phantom in a transmission mode 
and the optical properties of the tissue matrix (scattering and absorption coefficients). 
2. Materials and methods 
Tissue phantoms with inclusions and different optical properties are widely used to simulate 
tissues in optical spectroscopy and deep Raman techniques [13, 14]. The liquid phase of the 
phantoms allows high flexibility in the control of its optical properties. 
In this study, Intralipid and Indian ink were used to induce scattering and absorbance, 
respectively, in the liquid tissue phantoms. Intralipid, a dilute mixture of emulsified fatty 
acids serves as a scattering medium whereas Indian ink, a dispersion of carbon particles, acts 
as a wide spectrum absorbing agent. 
2.1 Tissue phantom optical properties 
The phantoms were prepared to include most of the range of optical properties found in 
tissues. Because these values vary considerably and can overlap between different types of 
tissues, it was important to explore which of the different tissue types would benefit the most 
from the diode signal enhancement. 
The optical properties of various tissues which we took into consideration are presented in 
Table 1 and their relative distribution and relation to the phantom properties in Fig. 1. The 
reduced scattering coefficients were calculated as a function of the excitation wavelength 
[15], whereas the absorption coefficients are based on literature values for skin [16], dermis 
[17], brain [18], white matter [19], breast [15, 20], fat [21], bone [22], liver [23]- at 850 nm, 
muscle [21], small bowel [24], aorta [25], stomach wall [26]. For prostate tissue both the 
reduced scattering and absorption coefficients were extracted from separate studies [27, 28]. 
Table 1. Optical properties of the different types of mammalian tissue as found in the 
literature. The reduced scattering coefficient values are presented in ascending order. 
Tissue Reduced scattering coefficient 
(cm−1) [15] 
Absorption coefficient (cm−1) 
Liver 6.58 0.6- 1 [23] 
Prostate 4-9.5 [27, 28] 0.002- 0.7 [27, 28] 
Aorta 7.07 3.16 [25] 
Muscle 8.13 0.2- 0.3 [21] 
Small bowel 8.80 0.05- 0.2 [24] 
White matter brain 9.41 0.75- 1.15 [19] 
Breast 9.84 0.068- 0.102 [20] 
Brain (mean) 10.70 0.4 [18] 
Stomach wall 11.68 2 [26] 
Fat (mean) 13.09 0.02 [21] 
Bone 15.93 0.2 [22] 
Skin (mean) 22.39 0.25 [16] 
Dermis 23.53 3 [17] 
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Fig. 1. Reduced scattering and absorption coefficient for different types of mammalian tissues 
obtained from literature data. Each sphere represents the range of optical properties for each 
individual type of tissue. The cross (shown with labels in Fig. 3) indicates the range of optical 
properties of the phantoms in the current study. 
2.2 Tissue phantom preparation 
The liquid tissue phantoms consisted of an optically clear quartz cell (45 mm width × 30 mm 
length (26 mm internal cell optical path length) × 45 mm height) (ramé-hart instrument co., 
USA) and contained aqueous solutions of Intralipid (20% emulsion, Sigma) and Indian ink 
(Histology Stain, American MasterTech), in various concentrations. 
A thin vial (outer size: 12 mm width, 4 mm length; inner size: 10 mm width, 2 mm length 
in optical axis) filled with trans-stilbene and suspended from a motorized translation stage 
(8MTF-102LS05, Standa Ltd, Lithuania), was placed inside the quartz cell (Fig. 2). The vial 
width (12 mm) was aligned with the y-axis and the 4 mm length was aligned with the optical 
axis of the system (x-axis). Using the motorized stage, the trans-stilbene vial was moved to a 
number of different positions (depths) in a two-dimensional horizontal grid, inside the quartz 
cell during each mapping. 
 
Fig. 2. (i) Liquid tissue phantoms components. (ii) Photon diode placed inside a metal plate 
and inserted inside the quartz cell in contact with the laser beam entrance wall when 
undertaking photon diode measurements. 
As stated above the liquid tissue phantoms were designed to simulate human breast and 
prostate tissue (amongst others) both in size [29, 30] and optical properties. Trans-stilbene 
was selected for its high Raman cross-section and represents a localized region of abnormal 
tissue, e.g. a zone with micro-calcifications, which are often found in different types of 
cancerous tissues and have a distinctly different Raman signal from surrounding soft tissues 
(Intralipid and ink solution here). The purpose of the experiment was to study the effect of the 
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photon diode on the Raman signal detected from the trans-stilbene vial at each location within 
the cell. The differences in Raman cross section between micro-calcifications and trans-
stilbene are largely irrelevant in this study as the effect of the photon diode is linear in its 
nature and therefore the same enhancement factors would be achieved irrespectively of the 
magnitude of Raman scattering cross section of the material within the cell (other properties 
such as scattering and zero-absorption of trans-stilbene powder at the excitation and detection 
spectral ranges, were assumed to be approximately the same as for micro-calcifications). 
In order to elucidate the role of both the absorption and scattering properties on the diode 
enhancement effect, the liquid tissue phantom studies were divided into two groups (Fig. 3): 
a) Liquid tissue phantom measurements with a constant absorption coefficient (μa = 0.8 
cm−1) and a varying reduced scattering coefficient (μ’s = 4.6-23.0 cm−1) 
b) Liquid tissue phantom measurements with a constant reduced scattering coefficient 
(μ’s = 13.8 cm−1) and a varying absorption coefficient (μa = 0-1.63 cm−1) 
 
Fig. 3. Scatterer and absorber concentrations (a) and optical properties (b) of the liquid tissue 
phantoms prepared and measured with transmission Raman spectroscopy. 
The liquid tissue phantoms were prepared and characterized in optical properties ranges 
similar to our previous study [12] in order to match a clinically relevant range. During the 
phantom fabrication, Intralipid was used as a scatterer and Indian ink as an absorber agent. 
Using literature values of reduced scattering coefficient for 10%, 20% and 30% of Intralipid 
[31] and extrapolating to values of lower concentration which agree with other studies [32–
34] we calculated the Intralipid concentrations equivalent to the required reduced scattering 
coefficient values for our phantoms. For the Indian ink characterization, UV/Vis absorption 
spectra have been recorded for different ink concentrations and the values extracted for the 
appropriate wavelength (830 nm) to calculate the appropriate ink concentrations required for 
our phantoms [35]. It should be mentioned here that during the phantom characterization, 
Intralipid is assumed to have no absorption and Indian ink no scattering. 
The optical properties of liquid tissue phantoms used are summarized in Table 2. 
Table 2. Optical properties of the liquid tissue phantoms used in the study. The material 
used to provide the distinct Raman signal at given locations was trans-stilbene. 
 μ′s (cm−1) μa (cm−1) 
Phantom 1 13.82 0 
Phantom 2 13.82 0.37 
Phantom 3 13.82 0.8 
Phantom 4 13.82 1.22 
Phantom 5 13.82 1.63 
Phantom 6 4.6 0.8 
Phantom 7 9.2 0.8 
Phantom 8 18.4 0.8 
Phantom 9 23.04 0.8 
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It should be noted that during the study, the Intralipid absorption at 830 nm was checked 
before each experiment by recording UV/Vis measurements, for precipitation of lipid 
aggregates in order to ensure the preservation of its stability and consistency. Additionally, 
prior to sample preparation, the Indian ink was always subjected to ultrasound agitation in an 
ultrasonic bath for 30 minutes in order to prevent solution instability and ensure 
reproducibility of optical properties [36, 37]. 
2.3 Deep Raman setup 
We have used a deep Raman system at the University of Exeter arranged in a transmission 
Raman configuration. The setup is shown in Fig. 4. It consisted of a spectrum stabilized laser 
(Innovative Photonics Solutions) with laser emission at 830 nm and an output power of ∼300 
mW. The laser light was coupled to a Thorlabs 400 μm multimode patch cord, collimated at 
exit and filtered by passing through a pair of laser line filters (FL830-10, Thorlabs) in order to 
suppress the amplified spontaneous emission (ASE) from the laser and other unwanted 
emission born in the optical fibre. The laser beam was directed towards the sample with a 
mirror and brought onto the sample with a 25 mm diameter, 70 mm focal length lens. The 
sample was illuminated with 280 mW of light in a 3–4 mm diameter spot. The collimated 
light passing through the tissue phantom is either scattered or absorbed by the sample 
components present. The Raman scattered photons were collected on the other side of the 
phantom using a lens (f = 60 mm, dia. = 50 mm, AR coated, INGCRYS Laser systems). The 
collimated scattered light was passed through a holographic super notch filter (HSPF-830.0 
AR-2.0, Kaiser Optical Systems) to remove the elastically scattered light (laser photons) and 
imaged onto a fibre probe bundle by a second lens of the identical parameters to the collection 
lens (i.e. no magnification was present). The fibre bundle (CeramOptec, ‘spot to slit line’ type 
bundle assembly, active area spot diameter approximately 2.2 mm, slit line of approximately 
0.22 × 15.0 mm dimensions) was connected to the entrance port of a Holospec VPH system 
spectrograph (Kaiser Optical systems Inc, HSG-917.4 custom). The Raman spectra were 
recorded using a deep depletion CCD camera cooled down to −75 °C (Andor Technology, 
DU420A-BR-DD, 1024 × 255 pixels). The overall spectral resolution of the detection system 
was ∼8 cm−1. 
 
Fig. 4. Schematic diagram of the deep Raman setup in the transmission mode used. 
In order to explore the properties of diode enhancement on Raman signal, a photon diode 
element (Semrock, 830 nm, with FWHM bandwidth measured as 9.5 nm, BrightLine® single-
band bandpass filter – 25 mm diameter with overall 3.5 mm thickness) was mounted at the 
center of a metal plate which was then placed at the front of the quartz cell against its internal 
wall (see Fig. 2). The metal plate outside the active area of the photon diode was covered with 
an aluminium reflecting foil, in order to achieve the maximum reflectance of re-emerging 
photons back to the phantom also outside the laser illumination zone. During the control 
(without a photon diode) measurements, a quartz window of identical dimensions was placed 
at the same location in order to make up for the loss of liquid phantom volume and to retain 
the identical mapping pattern. Additionally, a calcium fluoride disc (20 mm diameter, 1 mm 
thickness) was placed between the diode/quartz and the cell wall during every measurement, 
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in order to minimize the solution volume trapped in the interface which would potentially lead 
to disruption of the collimated laser beam. 
2.4 Raman mapping 
In order to explore the diode enhancement effect on Raman signal through the different liquid 
tissue phantoms, we recorded the Raman spectra of the tissue phantom when the trans-
stilbene vial was at 42 different positions on the optical axis of the setup. At each location the 
signal was collected using 6 accumulations of 5 seconds (30 s overall) and the cosmic ray 
removal option of the detector software (Andor Solis) was applied. The system was calibrated 
using Raman bands of an aspirin tablet (acetylsalicylic acid). 
A motorized x-y translation stage was used to move the vial between different positions, 
in a ‘snake’-like pattern (starting from the laser entrance side and moving towards the exit 
side of the cell). While recording the 1D maps, the step size on the x axis varied between 1 
mm around the center of the phantom (between 8 and 14 mm from the illumination side) and 
2 mm on the edges of the phantom (the rest of the mapping area). On the y axis only the main 
beam area (between 21 and 23 mm) was scanned, using 1 mm step size. At each step, a 
Raman spectrum was recorded and the stage was moved to the next position. In order to 
provide confidence in the results, each phantom was mapped three times at the same 
locations. The mean and the standard deviation were calculated and displayed as error bars in 
the plots. 
For the 2D plot generated from the Phantom 3 map (Fig. 5), the vial was positioned at 176 
different locations inside the quartz cell within the x-y (horizontal) plane. To make most 
efficient use of the experimental time, the area of the y axis covered was between 12 and 32 
mm distance from the top edge of the cell. On the y axis, the step size was 1 mm in the main 
beam area (between 18 and 28 mm) and 2 mm on the rest of the mapping area. On the x-axis 
the mapping was performed with a 2 mm step size for the full accessible length of the 
phantom (0-20 mm). 
2.5 Data analysis 
All data were loaded into Matlab R2013a (MathWorks), where they were subjected to 
baseline correction using asymmetric least squares smoothing [38] and principal component 
(PC) noise reduction. Principal component analysis, a statistical method which is more 
commonly used to reveal the spectral variance throughout a data set, is also useful for 
minimizing the noise in a set of spectra by reconstructing it only from the significant principal 
components (in our case the first seven PCs). In this way, all of the important spectral 
information is retained, whereas the background noise is being removed [39, 40]. For the 1D 
plots, the mean intensity on the y axis was calculated in order to directly compare the values 
between the different maps. 
Both one and two dimensional plots of the signal distributions are given. These plots 
display the trans-stilbene peak intensity, at each spatial location in the phantoms, at 1193 
cm−1 for all the phantoms except for Phantom 1 (phantom with zero absorption), where 1594 
cm−1 peak has been used instead, in order to avoid saturation issues. 
3. Results 
3.1 Effect of photon diode on the origin of Raman signal within the liquid phantoms 
To evaluate the impact of the photon diode on the signal enhancement and the origin of 
Raman scattering, we first recorded a full map of Phantom 3 (μ’s = 13.82 cm−1, μa = 0.8 cm−1) 
with and without the photon diode (Fig. 5). The color of the pixels indicates the peak intensity 
of 1193 cm−1 from trans-stilbene at each location. 
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 Fig. 5. Raman scattering 2D plots of Phantom 3 (μ’s = 13.82 cm−1, μa = 0.8 cm−1) with (a) and 
without (b) the photon diode in a transmission mode. Laser photons are injected on the left of 
the image and Raman signal is collected on the right. The plots depict the intensity of ~1193 
cm−1 Raman band of trans-stilbene as the vial moves to different positions in the phantom. The 
2D plot (b) has been normalized against the maximum intensity of the diode map (a). 
The photon diode provided an enhancement factor of ~ × 1.7 on the front of the phantom 
(closer to the illumination side) which decreased and remained stable in the middle of the 
phantom. This 2D plot is consistent with the results presented in the next part, where a variety 
of optical properties were explored. 
3.2 Diode enhancement in phantoms with varying reduced scattering coefficient 
The trans-stilbene generated Raman scattering has been recorded along the optical axis in 
phantoms with varying reduced scattering coefficient and a constant concentration of Indian 
ink. 
 
Fig. 6. Ratio of trans-stilbene Raman signal intensity with diode over signal without the diode 
versus the trans-stilbene vial position along the x-axis in the phantom (mm), for phantoms with 
the same absorption but different scattering coefficients. The coefficients are presented in cm−1. 
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The reduced scattering coefficient values explored were in the range of 4.6 – 23.04 cm−1. 
For clarity and brevity, the ratio of the trans-stilbene signal with the diode over the signal 
without the diode, was plotted against the phantom depth of the trans-stilbene vial, for 
phantoms with different optical properties, on the same plot (Fig. 6). The greatest 
enhancement factor for the phantoms with varying scattering, is observed on the measurement 
points with the closest proximity to the diode (0 mm). At this depth, phantoms with lower 
optical properties exhibit higher Raman signal with the diode, as the generated Raman 
photons cross the phantom bulk on the other side of the vial and are collected from the optics 
more efficiently in low scattering values. When the vial is positioned in a distance from the 
diode, the phantoms with the higher scattering benefit from the photon diode the most, with 
enhancement factors ranging between 1.17 and 1.83. The reason for that is that due to lower 
diffuse scattering, the low scattering phantoms do not benefit as much from the back-
scattering enhancement mechanism of the diode. As a result, in a higher scattering 
environment, there is greater enhancement from the photon diode as the photons which re-
enter the phantom volume reach the vial more easily due to diffuse scattering. In this way, the 
bulk volume of the phantom is the zone benefiting most from the presence of the photon 
diode. The signal enhancement decreases as we move towards (0-4 mm) and it seems to 
plateau when the trans-stilbene vial is located around the middle of the phantom (4-16 mm). 
The enhancement factors in this area appear to fall to a similar range (1.0-1.2) for most of the 
phantoms. Towards the back of the phantom and closer to the collection side (16-20 mm), the 
diode enhancement of the signal seems to be decreasing even more. This drop is in some 
cases so sharp (e.g. Phantom 8: μs’ = 23.04 cm−1 and μa = 0.8 cm−1), that the diode might not 
be beneficial for signal enhancement at all. It should be noted that at high scattering 
coefficient values (18.4 cm−1 and 23.04 cm−1), the enhancement at the back of the phantom 
does not follow the same trend as at the front. The drop is most likely due to the overall lower 
transmittance of the diode compared to quartz layer (by around 10%). 
3.3 Diode enhancement in phantoms with varying absorption coefficient 
Similar trends are observed in phantoms with varying absorption coefficients and constant 
reduced scattering coefficient (concentration of Intralipid) (Fig. 7). The signal enhancement 
from the diode here seems to be almost constant through many vial depths in each of the 
different phantoms. The absorption appears to affect the diode enhancement to a greater 
extent compared to the scattering case, since the enhancement ratio drops quicker when we 
increase the absorption coefficient (ink concentration) rather than the scattering coefficient. 
Comparing the two plots (Fig. 6 and Fig. 7), it seems that a middle value of absorption (μa = 
0.8 cm−1) inhibits the signal enhancement in the middle of the phantom more compared to a 
middle scatterer value (μs’ = 13.82 cm−1). This means that it is less likely for the ‘enhanced’ 
laser photons to generate a Raman photon which will get detected on the collection side in the 
presence of ink. On the other hand, when only Intralipid concentration is increased, the 
absorption increases indirectly due to the path length change too, but not to such an extent. 
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Fig. 7. Ratio of trans-stilbene signals with diode over signal without the diode versus the trans-
stilbene vial position along the x-axis in the phantom (mm), for phantoms with same scattering 
but different absorption coefficients. The coefficients are presented in cm−1. 
In terms of the enhancement factor in the varying absorption phantoms, it takes a wide 
range of values through the entire phantom depth as the vial is moved across towards the 
collection side. The highest enhancement factor is again observed at the points closest to the 
diode (0 mm) and it takes different values between 0.95 and 2.34, depending on the absorber 
agent introduced in each phantom. As expected, the highest signal enhancement is observed in 
the phantom with no absorption and as soon as 0.1 μl/ml of ink is present, equivalent to μa of 
0.37 cm−1, the signal enhancement drops from 2.34 to 2.21. In the middle area of the phantom 
(4-16 mm), the signal enhancement has gradually decreased and reached a plateau. Towards 
the back of the phantom (16-20 mm), the signal enhancement seems to be decreasing even 
more and for the extreme ink concentration (Phantom 5: μa = 0.8 cm−1 and μs’ = 13.82 cm−1), 
the benefit of using a photon diode is limited, as the signal enhancement ratio constantly 
remains close or under 1. As mentioned before, the values below 1 can be attributed to the 
reduced transmittance of photon diode which becomes especially significant in high optical 
properties phantoms with low signal to noise ratios. 
It should be noted that a reduced signal on the edge of the sample is less detrimental to the 
detection sensitivity than it would be in the centre of the sample, as signals tend to be 10-50% 
higher at the edges than in the centre for tissue optical properties [12]. 
4. Conclusion 
In this series of experiments, we have demonstrated the signal enhancement potential of 
photon diode in tissue phantoms with varying optical properties. It was shown that the gradual 
introduction of absorber agent affects the signal enhancement more strongly compared to a 
scatterer increase. 
The enhancement factors observed through the measurements are in the range of 1-2.4. 
Similar studies on pharmaceutical tablets have exhibited an enhancement as high as × 10 [7]. 
However, the optical properties of these samples (e.g. lack of absorption) are quite different 
and their physical dimensions and those of illumination and collection zones are also different 
to those of biological tissues. To date, biological samples of similar thickness reported in the 
literature, show an enhancement of ~1.5 times for the entire sample matrix when measured in 
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a transmission setup using a photon diode [4, 8]. These observations are in broad agreement 
with our results although these reports do not include any enhancement studies involving 
inclusions inside the phantoms. Our study also demonstrates how the diode enhancement 
changes with varying scattering and absorption properties in samples with Raman scattering. 
Through our study, it is obvious that different tissue types will benefit to different extent 
from the use of photon diode. For example, based on the optical properties shown in Fig. 1, 
tissues such as liver, prostate, breast, muscle, fat, brain, bone and small bowel would benefit 
with at least × 1.2 signal enhancement in the bulk volume, whereas other tissues such as 
dermis, white matter, skin and stomach wall would not see any benefit due to their higher 
optical absorption and scattering properties. In those tissues with regions of interest near the 
illumination side the photon diode may achieve signal enhancements of × 1.5 to × 2.3. 
Where a signal enhancement is achieved it leads to enhanced detection sensitivity and 
penetration depth for transmission Raman measurements. Furthermore, the use of additional 
filters/mirrors on the remaining tissue/phantom sides (right, left, top, bottom and the 
collection sides) as indicated earlier [5] would provide the prospect for further improvements 
to Raman signal to noise ratios. 
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